NCT02190864

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 210 (estimated)
• Sponsor: University of Nebraska · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Our long-term goal is to integrate non-small cell lung cancer patient treatment preferences into clinical treatment planning.

Detailed description

The following specific aims are proposed: Aim 1: Determine whether individual patients' preferences, characteristics, and treatment experiences affect the definition of treatment success. Aim 2: Determine how to best predict real-life patients' treatment choices based on patients' preferences of adverse events. Aim 3: Determine whether physicians are likely to change their oncologic clinical practice after receiving a detailed communication of their patients' preferences of adverse events.

Conditions

• Particularly Rural/Urban Residence
• Gender
• Age
• FACT-TOI Scores
• Comorbid Conditions

Timeline

• Start date: 2013-12-01
• Primary completion: 2016-06-01
• Completion: 2016-06-01
• First posted: 2014-07-15
• Last updated: 2015-12-04

Locations

8 sites across 1 country: United States